EP 3463374 A1 20190410 - A LONG ACTING PHARMACEUTICAL COMPOSITION OF PROTEASE INHIBITOR
Title (en)
A LONG ACTING PHARMACEUTICAL COMPOSITION OF PROTEASE INHIBITOR
Title (de)
LANGWIRKENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG EINES PROTEASEHEMMERS
Title (fr)
COMPOSITION PHARMACEUTIQUE À ACTION PROLONGÉE À BASE D'UN INHIBITEUR DE PROTÉASE
Publication
Application
Priority
US 2016035029 W 20160531
Abstract (en)
[origin: WO2017209732A1] Disclosed herein is a long acting pharmaceutical composition for treating or preventing human immunodeficiency virus (HIV) infection. The pharmaceutical composition comprises a suspension of a lysine-based aspartyl protease inhibitor or salt thereof, a surface modifier, and a pharmaceutically acceptable carrier; wherein the lysine-based aspartyl protease inhibitor or salt thereof has an average effective particle size of less than about 500 nm. A method for treating or preventing HIV infection with the pharmaceutical composition is also disclosed.
IPC 8 full level
A61K 31/551 (2006.01); A61K 31/18 (2006.01); A61K 31/498 (2006.01)
CPC (source: EP)
A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 9/5146 (2013.01); A61K 31/63 (2013.01); A61K 31/661 (2013.01); A61P 31/18 (2017.12)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017209732 A1 20171207; CN 109475563 A 20190315; EP 3463374 A1 20190410; EP 3463374 A4 20200122; JP 2019510002 A 20190411; JP 6704058 B2 20200603
DOCDB simple family (application)
US 2016035029 W 20160531; CN 201680085468 A 20160531; EP 16904195 A 20160531; JP 2018544210 A 20160531